Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene
Open Access
- 3 August 2009
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 58 (11) , 2616-2623
- https://doi.org/10.2337/db09-0279
Abstract
OBJECTIVE In a genome-wide association scan, the rs738409 C>G single nucleotide polymorphism (SNP) in the patatin-like phospholipase 3 gene (PNPLA3) was strongly associated with increased liver fat but not with insulin resistance estimated from fasting values. We investigated whether the SNP determines liver fat independently of visceral adiposity and whether it may even play a role in protecting from insulin resistance. RESEARCH DESIGN AND METHODS Liver fat was measured by 1H magnetic resonance spectroscopy and total and visceral fat by magnetic resonance tomography in 330 subjects. Insulin sensitivity was estimated during an oral glucose tolerance test and the euglycemic-hyperinsulinemic clamp (n = 222). PNPLA3 and tumor necrosis factor-α mRNA and triglyceride content were measured in liver biopsies from 16 subjects. RESULTS Liver fat correlated strongly with insulin sensitivity (P < 0.0001) independently of age, sex, total fat, and visceral fat. G allele carriers of the SNP rs738409 had higher liver fat (P < 0.0001) and an odds ratio of 2.38 (95% CI 1.37–4.20) for having fatty liver compared to C allele homozygotes. Interestingly, insulin sensitivity (oral glucose tolerance test: P = 0.99; clamp: P = 0.32), serum C-reactive protein levels, lipids, or liver enzymes (all P > 0.14) were not different among the genotypes. Additional adjustment for liver fat actually revealed increased insulin sensitivity in more obese carriers of the G allele (P = 0.01). In liver biopsies triglyceride content correlated positively with expression of the proinflammatory gene tumor necrosis factor-α in C allele homozygotes (n = 6, P = 0.027) but not in G allele carriers (n = 10, P = 0.149). CONCLUSIONS PNPLA3 may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences.Keywords
This publication has 52 references indexed in Scilit:
- Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart StudyAmerican Journal of Gastroenterology, 2008
- Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver EnzymesPublished by Elsevier ,2008
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Fetuin-A and Incident Diabetes Mellitus in Older PersonsJAMA, 2008
- Advances in Male ContraceptionEndocrine Reviews, 2008
- Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseJournal of Clinical Investigation, 2007
- Inflammation and metabolic disordersNature, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 2005
- Standardized assessment of whole body adipose tissue topography by MRIJournal of Magnetic Resonance Imaging, 2005